Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations

Early-Onset Neonatal Sepsis Clinical Trial

Official title:
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations With High Risk for EOS

Status Recruiting

Clinical Trial Summary

The purpose of this study is to describe the population pharmacokinetic characteristics of piperacillin/tazobactam after intravenous administration in pregnant women during pregnancy and delivery, and to evaluate pharmacodynamic effectiveness and safety of piperacillin/tazobactam in pregnant women whose baby are at high risk of developing early-onset sepsis after birth.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06076200
Study type	Observational
Source	Shandong University
Contact	Wei Zhao, Ph.D
Phone	86053188383308
Email	zhao4wei2@hotmail.com
Status	Recruiting
Phase
Start date	September 30, 2023
Completion date	December 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03694613` - Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants	N/A
Recruiting	`NCT03819192` - Predicting EONS in PPROM Patients
Recruiting	`NCT03997266` - NICU Antibiotics and Outcomes Trial	Phase 4
Recruiting	`NCT05329701` - Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.	Phase 4
Not yet recruiting	`NCT06377397` - Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates	Phase 3
Recruiting	`NCT06197269` - Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis	N/A
Not yet recruiting	`NCT06100614` - Presepsin to Safely Reduce Antibiotics in Preterm Infants	N/A
Not yet recruiting	`NCT05796115` - PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS	N/A